Related Experiment Videos
Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.
Carlos Morgan1, Manuel P Bugueño, Jorge Garrido
1Departamento de Biología Celular y Molecular, MIFAB, Facultad de Ciencias Biológicas, Centro de Regulación Celular y Patología, Pontificia Universidad Católica de Chile, Casilla 114-D, Santiago, Chile.
Peptides
|July 20, 2002
Summary
Laminin proteins and their peptides can inhibit Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
- Alzheimer's Disease Research
Background:
- Amyloid deposition forms neurotoxic plaques in Alzheimer's disease.
- Associated proteins can modulate this amyloid fibril formation process.
Purpose of the Study:
- To investigate the inhibitory effects of laminin-1 and laminin-2 on amyloid fibril formation and neurotoxicity.
- To evaluate specific laminin-derived peptides (YFQRYLI and IKVAV) for their anti-amyloidogenic and neuroprotective properties.
Main Methods:
- In vitro assessment of amyloid fibril formation.
- Neurotoxicity assays using cultured rat hippocampal neurons.
- Analysis of preformed fibril disaggregation by laminin-1.
Main Results:
- Laminin-1 and laminin-2 inhibited amyloid fibril formation and neurotoxicity.
- The YFQRYLI peptide effectively inhibited both fibril formation and neurotoxicity.
- The IKVAV peptide inhibited neurotoxicity, with only slight inhibition of fibril formation.
- Laminin-1 induced disaggregation of preformed fibrils, reducing neurotoxicity.
Conclusions:
- Laminin proteins and their derived peptides show potential in combating amyloid pathology in Alzheimer's disease.
- Targeting fibril formation, disaggregation, and neurotoxicity are viable strategies for therapeutic intervention.